Pfizer Whistleblower Alleges Separate COVID-19 Vaccines for Employees

A Pfizer whistleblower leaked an internal email showing the company offered "separate and distinct" COVID-19 vaccines to employees at its Pearl River research site in 2021. The email stated these vaccinations would not impact the global vaccine supply, raising questions about differences between employee and public vaccines.

Bijay Laxmi
New Update
Pfizer Whistleblower Alleges Separate COVID-19 Vaccines for Employees

Pfizer Whistleblower Alleges Separate COVID-19 Vaccines for Employees

A whistleblower from Pfizer has come forward with a leaked internal email from January 2021, revealing that the pharmaceutical giant provided a "separate and distinct" COVID-19 vaccine to employees at its Pearl River research site in Rockland County, New York. The email, addressed to colleagues and contractors at the site, informed them that they would be offered exclusive vaccinations that would not impact the supply of doses committed to governments worldwide.

Why this matters: This revelation raises concerns about the transparency and accountability of pharmaceutical companies involved in the global vaccination effort, and it has significant implications for public trust in the safety and efficacy of COVID-19 vaccines. If true, it could lead to a re-examination of the vaccination rollout and potential changes to the way vaccines are developed, tested, and distributed.

The whistleblower, who remains anonymous, told Infowars,"I know we employees at Pfizer were receiving different vaccines and/or placebos and this was the word around my site when I worked there. "Theleaked documentidentifies "site-essential workers" as those eligible for these special vaccinations.

Pfizer issued a statement confirming that site-essential employees are those based at manufacturing and R&D sites whose presence is required to ensure the supply of medicines and vaccines, the continuation of critical research and development programs, and to maintain and keep labs and buildings secure. ThePearl River research siteis one of Pfizer's nine major R&D sites and is the primary location for its global Vaccine Research and Development work, focused on developing an mRNA-based coronavirus vaccine.

This revelation is not an isolated incident. In 2021, Kildare Live reported that around 15,000 staff and contractors at Pfizer plants across the EU would receive the vaccine as part of a similar initiative. The Newbridge plant in County Kildare, Ireland, also participated, with several hundred employees receiving the Pfizer/BioNTech vaccine.

Furthermore, during a Senate hearing in Australia, Dr. Brian Hewitt, Head of Regulatory Sciences at Pfizer Australia, revealed that the company had imported a special batch of COVID-19 vaccines solely for their employee vaccination program. "Pfizer undertook to import a batch of vaccine specifically for the employee vaccination programme, and that was so that no vaccine would be taken from government stocks that was being delivered to clinics as needed,"Hewitt stated during the rigorous questioning session.

The leaked email from the Pfizer whistleblower raises serious questions about the differences between the COVID-19 vaccines provided to the company's employees and those distributed to the general public. As more information comes to light, it becomes increasingly clear that select individuals may have received different jabs or even placebos compared to the wider population. The implications of these revelations demand further investigation and transparency from Pfizer and other pharmaceutical companies involved in the global vaccination effort.